Out-licensing

The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success.

The ORS effervescent tablet has been developed and succesfully introduced in the Netherlands, a marketshare of 25% was accomplished within the first year.

The development of the ORS (Oral Rehydration Salts) effervescent tablet is a successful project of Focus Care Phamaceuticals. The product has been developed according to WHO guidelines. The usual dosage form for ORS is in sachet but we were convinced that a better form was possible. We succeeded to combine a lot of advantages in our product. 

The major advantages of the effervescent tablets are:

• Convenience and speed 
• Desintegration time < 1 minute in glass of water 
• Completely dissolves, no remaining residues
• Taste
• Fresh lemon flavour
• More 'lemonade' than 'medicine', easy to drink for kids.
• Premium product
• A premium and unique dosage form, much more appreciated than sachet 
• More attractive price structure. The customer is willing to pay a premium price.

Registered

We are looking for partnerships to commercialize the ORS effervescent tablets in Europe and other territories.